Person

Richard Alexander Collins

Director, Dexcom

Current S&P 500 boards
1
Current roles
1
Open-market buys
$0
Open-market sales
$2.5M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

None on record since 2016.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Nov 14, 2025DXCMSale2,906$59.05$172K
Nov 10, 2025DXCMSale3,948$55.17$218K
Nov 3, 2021DXCMSale1,500$647.05$971K
Feb 18, 2020DXCMSale4,000$284.40$1.1M

SEC reporting-owner ID (CIK) 1700619 · all filings on EDGAR